Literature DB >> 25636478

Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.

Federica Maione1, Enrico Giraudo.   

Abstract

Angiogenesis, the formation of neo-vessels, is one of the most important hallmarks of cancer. Tumor vasculature presents structural abnormalities such as dilatation of vessel diameter and hyper-branched and twisted pattern. A promising strategy in anticancer therapy to overcome the resistance to certain antiangiogenic therapies is the tumor blood vessel normalization, which restores the physiological perfusion and oxygenation of tumor vasculature. Many studies showed how vessel normalization is able to counteract metastasis formation and to favor chemotherapeutic drugs delivery to tumors. Herein we describe different techniques and protocols that allow the study, in vivo the main features of tumor vessel normalization such as the reduction of vessel branching and diameter, the increase of pericyte coverage, the reduction of vessel permeability, and the improvement of vessel perfusion and drug delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636478     DOI: 10.1007/978-1-4939-2297-0_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma.

Authors:  May Elbanna; Ashley R Orillion; Nur P Damayanti; Remi Adelaiye-Ogala; Li Shen; Kiersten Marie Miles; Sreenivasulu Chintala; Eric Ciamporcero; Swathi Ramakrishnan; Sheng-Yu Ku; Karen Rex; Sean Caenepeel; Angela Coxon; Roberto Pili
Journal:  Mol Cancer Ther       Date:  2019-10-03       Impact factor: 6.261

2.  Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.

Authors:  Junfeng Zhang; Wei Xue; Kai Xu; Liang Yi; Yu Guo; Tian Xie; Haipeng Tong; Bo Zhou; Shunan Wang; Qing Li; Heng Liu; Xiao Chen; Jingqin Fang; Weiguo Zhang
Journal:  Theranostics       Date:  2020-06-05       Impact factor: 11.556

3.  Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.

Authors:  V Leuci; F Maione; R Rotolo; E Giraudo; F Sassi; G Migliardi; M Todorovic; L Gammaitoni; G Mesiano; L Giraudo; P Luraghi; F Leone; F Bussolino; G Grignani; M Aglietta; L Trusolino; A Bertotti; D Sangiolo
Journal:  J Transl Med       Date:  2016-05-05       Impact factor: 5.531

4.  Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.

Authors:  Yanwei Shen; Shuting Li; Xin Wang; Mengying Wang; Qi Tian; Jiao Yang; Jichang Wang; Biyuan Wang; Peijun Liu; Jin Yang
Journal:  J Exp Clin Cancer Res       Date:  2019-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.